Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease

Cerebral Cortex

Volumn 6, Issue 2, 1996, Pages 165-177

  Geula, Changiz ^a   Mesulam, M Marsel ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CELL DENSITY; CELLULAR DISTRIBUTION; CHOLINERGIC NERVE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; CHOLINERGIC FIBERS; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; TISSUE DISTRIBUTION;

EID: 0029963924     PISSN: 10473211     EISSN: None     Source Type: Journal    
DOI: 10.1093/cercor/6.2.165     Document Type: Article

References (27)

1. Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Mislikin M (1987) Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Psychopharmacology (Berl) 92:292-300.
2. Aletrino MA, Vogels OJM, Van Domberg PH, Ten Donkelaar HJ (1992) Cell loss in the nucleus raphe dorsalis in Alzheimer's disease. Neurobiol Aging 461-468.
3. Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R (1988) Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 50:1914-1923.
4. Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and korsakoff's disease. Acta Neuropathol (Berl) 61:101-108.
5. Arendt T, Bigl V, Tennstedt A, Arendt A (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 14:1-14.
6. Bird TD, Stranaham S, Sumi SM, Raskind M (1983) Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 14:284-293.
7. Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459-496.
8. Bowen DM, Spillane JA, Curzon G, Meier-Ruge W, White P, Goodhardt MJ, Iwangoff P, Davison AN (1979) Accelerated ageing or selective neuronal loss as important cause of dementia? Lancet 1:11-14.
9. Bowen DM, Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Palmer AM, Sims NR, Smith CT, Spillane JA, Esiri MM, Neary D, Snowdon JS, Wilcock GK, Davison AN (1983) Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem 41:266-272.
10. Brashear HR, Codec MS, Carlsen J (1988) The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer's disease. Neurology 38:1694-1699.
11. Cross AJ, Crow TJ, Ferrier IN, Johnson JA, Bloom SR, Corsellis JAN (1984) Serotonin receptor changes in dementia of the Alzheimer type. J Neurochem 43:1574-1581.
12. D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH (1987) Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol 22:229-236.
13. Davies P (1979) Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 171:319-327.
14. Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
15. DeKosky ST, Scheff SW, Markesbery WR (1985) Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging. Neurology 35:1425-1431.
16. DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RAE, Chui HC, Knopman DS, Reeder TM, Shelter AG, Senter HJ, Markesbery WR (1992) Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlates. Ann Neurol 32:625-632.
17. Dokla CJ, Thal LJ (1988) Effect of cholinesterase inhibitors on Morris water task behavior following lesions of the nucleus basalis magnocellularis. Behav Neurosci 102:861-871.
18. Doucette R, Ball MJ (1987) Left-right symmetry of neuronal cell counts in the nucleus basalis of Meynert of control and of Alzheimer-diseased brains. Brain Res 422:357-360.
19. Drachman DA, Leavitt J (1974) Human memory and the cholinergic system: a relationship to aging? Arch Neurol 30:113-121.
20. Emre M, Heckers S, Mash DC, Geula C, Mesulam M-M (1993) Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease. J Comp Neurol 336:117-134.
21. Etienne P, Dastoor D, Gauthier S, Ludwick R, Collier B (1981) Alzheimer's disease: lack of effect of lecithin treatment for 3 months. Neurology 31:1552-1554.
22. Etienne P, Robitaille Y, Wood P, Gauthier S, Nair NPV, Quirion R (1986) Nucleus basalis neuronal loss, neuritic plaques, and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 19:1279-1291.
23. Flicker C, Dean RL, Watkins DL, Fisher SK, Bartus RT (1983) Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol Biochem Behav 18:973-981.
24. Francis PT, Bowen DM (1989) Tacrine, a drug with therapeutic potential for dementia: post-mortem biochemical evidence. Can J Neurol Sci 16:504-510.
25. German DC, Bruce G, Hersh LB (1985) Immunohistochemical staining of cholinergic neurons in the human brain using a polyclonal antibody to human choline acetyltransferase. Neurosci Lett 61:1-5.
26. Geula C, Mesulam M-M (1989) Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study. Neuroscience 33:469-481.
27. Geula C, Mesulam M-M (1990) Human brain cortical cholinergic innervation. Soc Neurosci Abstr 16:1057.